Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NRG | CEG |
|---|---|---|
| Price | $95.87 | $259.00 |
| Change today | ▲ 0.23% | ▲ 1.96% |
| Market cap | $20.15B | $91.77B |
| Return, 3 months | -31.7% | +9.7% |
| Return, year to date | -39.2% | -26.4% |
| Return, 1 year | -40.1% | -25.8% |
| P/E (TTM) | 25.0 | 25.3 |
| P/B | 4.8 | 2.9 |
| P/E percentile vs own 5y | 77th | 43rd |
| Dividend yield | 1.91% | 0.63% |
| Revenue growth (YoY, latest qtr) | +11.0% | +23.0% |
| Net profit growth (YoY) | +586.5% | -39.0% |
| Gross margin | 18.8% | 21.4% |
| Operating margin | 6.3% | 17.8% |
| Net margin | 2.4% | 11.1% |
| Return on equity | 26.8% | 15.3% |
| Analyst target vs. price | +107.4% | +36.3% |
| Analyst buy share | 82% | 88% |
| RSI (14) | 31 | 39 |
| 30-day volatility | 40.2% | 37.9% |
| Max drawdown, 1 year | -47.7% | -41.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
